A potent, selective inhibitor of PDE7, inhibiting human recombinant PDE7A1 with a Ki value of 180 nM; enhances the inhibitory effects of the PDE4 blocker rolipram on monocytes, lung macrophgaes, and CD8+ T-lymphocytes; promotes apoptosis in chronic lymphocytic leukemia cells overexpressing PDE7B.